Get the Stockscreener App
0.3462
2.67%
-0.0095
After Hours:
.34
-0.0062
-1.79%
Vyne Therapeutics Inc stock is traded at $0.3462, with a volume of 1.06M.
It is down -2.67% in the last 24 hours and down -7.01% over the past month.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
See More
Previous Close:
$0.3557
Open:
$0.3569
24h Volume:
1.06M
Relative Volume:
0.45
Market Cap:
$8.82M
Revenue:
$476.00K
Net Income/Loss:
$-38.52M
P/E Ratio:
-0.3829
EPS:
-0.9041
Net Cash Flow:
$-39.89M
1W Performance:
-4.10%
1M Performance:
-7.01%
6M Performance:
-74.73%
1Y Performance:
-86.94%
1-Day Range:
$0.34
$0.3655
1-Week Range:
$0.331
$0.389
52-Week Range:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Name
Vyne Therapeutics Inc
Sector
Industry
Phone
800-775-7936
Address
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3462 | 9.06M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-18-24 | Initiated | BTIG Research | Buy |
| Dec-06-21 | Resumed | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Stock (VYNE) Latest News
Healthy Upside Potential: VYNE Therapeutics Inc (VYNE) - setenews.com
Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Declines By 29.5% - Defense World
Can swing trading help recover from VYNE Therapeutics Inc. losses2025 Price Action Summary & High Return Trade Guides - newser.com
Why analysts remain bullish on VYNE Therapeutics Inc. stock2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Institutional Moves & Free Daily Entry Point Trade Alerts - newser.com
Why VYNE Therapeutics Inc. stock could be next big winnerJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Vyne Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Signal strength of VYNE Therapeutics Inc. stock in tech scanners2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
What high frequency data says about VYNE Therapeutics Inc.2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Tools to monitor VYNE Therapeutics Inc. recovery probabilityWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
What earnings revisions data tells us about VYNE Therapeutics Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Understanding VYNE Therapeutics Inc.’s price movement2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Can technical indicators confirm VYNE Therapeutics Inc.’s reversalJuly 2025 Action & Pattern Based Trade Signal System - newser.com
Why VYNE Therapeutics Inc. stock is seen as undervaluedProfit Target & Consistent Return Investment Signals - newser.com
Is VYNE Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Using R and stats models for VYNE Therapeutics Inc. forecastingJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Is VYNE Therapeutics Inc. showing signs of accumulationTrade Ideas & Verified Stock Trade Ideas - newser.com
Will VYNE Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Vyne Therapeutics Inc Stock (VYNE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):